       Document 0697
 DOCN  M9620697
 TI    Transgenic models to assess the neuropathogenic potential of HIV-1
       proteins and cytokines.
 DT    9602
 AU    Mucke L; Masliah E; Campbell IL; Department of Neuropharmacology,
       Scripps Research Institute, La; Jolla, CA 92037, USA.
 SO    Curr Top Microbiol Immunol. 1995;202:187-205. Unique Identifier :
       AIDSLINE MED/96004236
 DE    Animal  *Animals, Transgenic  *AIDS Dementia Complex/PATHOLOGY
       Brain/PATHOLOGY  Cytokines/GENETICS/*PHYSIOLOGY  *Disease Models, Animal
       Gene Expression Regulation, Developmental  Genes, Structural  Genes,
       Structural, Viral  Glial Fibrillary Acidic Protein/GENETICS
       Granulocyte-Macrophage Colony-Stimulating Factor/GENETICS/  PHYSIOLOGY
       Human  HIV Envelope Protein gp120/GENETICS/PHYSIOLOGY
       HIV-1/GENETICS/*PATHOGENICITY  Interleukin-6/GENETICS/PHYSIOLOGY  Mice
       Mice, Transgenic  Promoter Regions (Genetics)  Rats  Recombinant Fusion
       Proteins/BIOSYNTHESIS  Retroviridae Proteins/GENETICS/*PHYSIOLOGY
       Species Specificity  Support, Non-U.S. Gov't  Support, U.S. Gov't,
       P.H.S.  Transgenes  JOURNAL ARTICLE  REVIEW  REVIEW, ACADEMIC

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

